业界动态国内医卫资讯
朗卡斯妥昔单抗联合利妥昔单抗在弥漫大B细胞淋巴瘤中引发安全性担忧
Medscape News · 2026-10-28 22:24
摘要
一项2期试验评估了朗卡斯妥昔单抗 tesirine 联合利妥昔单抗在既往未经治疗的弥漫大B细胞淋巴瘤老年、不适合或体弱患者中的安全性和有效性。Medscape医学新闻
English
Loncastuximab Plus Rituximab Raises Safety Concerns in DLBCL
A phase 2 trial evaluates the safety and efficacy of loncastuximab tesirine plus rituximab among older, unfit or frail patients with previously untreated diffuse large B-cell lymphoma. Medscape Medical News